C. Auris drug-resistant is a deadly threat to the rise of antibacterials

Global cases of infection known as Candida auris have become an "urgent threat", revealing the dangers of drug-resistant germs for bacteria and fungi from a cloud of secrecy about the fear of public hysteria, reported the New York Times.

"It's a huge problem," said Fisher Fisher, professor of fungal epidemiology at Imperial College London. "We depend on being able to treat these patients with antifungals."

The symptoms resemble those of the flu – fever, body aches and fatigue – and the drug-resistant "superbugs" are the most problematic for people, even fatal, with a weakened immune system, especially newborns, the elderly and diabetics, the report.

Antimicrobial soaps and medicines have long been held responsible for the evolution of these "superbugs" and their use in pesticides extends the issue to our food chain.

"On everything – potatoes, beans, wheat, everything you can imagine, tomatoes, onions – we get there through the use of antifungals on crops," told The Times Dr. Johanna Rhodes, expert in infectious diseases at Imperial College London.

The Center for Disease Control reports that nearly half of Candida auris patients die and that fungi spread very easily and can occupy a hospital room, prompting some hospitals to maintain the outbreak to prevent it from spreading. Public hysteria, according to the report.

"It's hard enough with these organizations to get health care providers around," said Dr. Anna Yaffee, a former CDC epidemic investigator. "It's really impossible to send a message to the public."